NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 89 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,513,062 | +6.8% | 1,414,076 | +158.6% | 0.00% | – |
| Q2 2023 | $1,416,412 | -35.7% | 546,877 | +1.3% | 0.00% | – |
| Q1 2023 | $2,202,000 | +77298.9% | 539,862 | -4.7% | 0.00% | – |
| Q4 2022 | $2,845 | -100.0% | 566,539 | +6.1% | 0.00% | -100.0% |
| Q3 2022 | $6,983,000 | -1.4% | 533,897 | -3.4% | 0.00% | 0.0% |
| Q2 2022 | $7,083,000 | -13.0% | 552,541 | +3.5% | 0.00% | 0.0% |
| Q1 2022 | $8,142,000 | -26.2% | 533,921 | -14.2% | 0.00% | 0.0% |
| Q4 2021 | $11,026,000 | -16.4% | 622,538 | -0.7% | 0.00% | -50.0% |
| Q3 2021 | $13,182,000 | +9.1% | 627,118 | +2.3% | 0.00% | +100.0% |
| Q2 2021 | $12,086,000 | +137.1% | 612,873 | +249.5% | 0.00% | 0.0% |
| Q1 2021 | $5,097,000 | -12.4% | 175,332 | -8.7% | 0.00% | 0.0% |
| Q4 2020 | $5,819,000 | +77.9% | 192,094 | -5.4% | 0.00% | 0.0% |
| Q3 2020 | $3,271,000 | -24.1% | 203,014 | -7.0% | 0.00% | 0.0% |
| Q2 2020 | $4,311,000 | +43.7% | 218,351 | -10.3% | 0.00% | 0.0% |
| Q1 2020 | $3,001,000 | -43.1% | 243,442 | -14.7% | 0.00% | 0.0% |
| Q4 2019 | $5,274,000 | +16912.9% | 285,265 | +12635.0% | 0.00% | – |
| Q3 2019 | $31,000 | +14.8% | 2,240 | +21.3% | 0.00% | – |
| Q2 2019 | $27,000 | – | 1,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 15,396,116 | $303,611,000 | 42.97% |
| Ponoi II Management, LLC | 1,298,908 | $25,614,000 | 20.76% |
| Ponoi Management, LLC | 1,298,908 | $25,614,000 | 14.23% |
| Euclidean Capital LLC | 1,493,349 | $29,449,000 | 9.56% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $74,279,000 | 6.80% |
| Aquilo Capital Management, LLC | 1,194,237 | $23,550,000 | 6.12% |
| Greenspring Associates, LLC | 1,573,357 | $31,027,000 | 2.10% |
| Octagon Capital Advisors LP | 200,000 | $3,944,000 | 0.82% |
| Redmile Group, LLC | 2,792,448 | $55,067,000 | 0.82% |
| BVF INC/IL | 955,000 | $18,833,000 | 0.71% |